Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela
NCT02756481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2016-04-29
Summary
To characterize treatment patterns and healthcare resource utilization among adults diagnosed with non-valvular atrial fibrillation (NVAF) from the private setting in Venezuela.
Conditions
- Non-Valvular Atrial Fibrillation
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
More Related Trials
-
Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2
NCT02488421 ·Status: COMPLETED
-
Cardiovascular Registry of Atrial Fibrillation
NCT04456842 ·Status: COMPLETED
-
The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF)
NCT02973984 ·Status: UNKNOWN
-
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
NCT02608099 ·Status: COMPLETED ·Phase: PHASE4
-
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation
NCT02459574 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
NCT00938730 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED
-
The Effect of Early Repeat Atrial Fibrillation (AF) Ablation on AF Recurrence
NCT01942408 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study
NCT04001205 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
NCT03788044 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
NCT04045639 ·Status: COMPLETED
-
Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
NCT00267930 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation
NCT00863213 ·Status: COMPLETED ·Phase: PHASE4
-
Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter
NCT00318565 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Risk Factors for Atrial Fibrillation After Ablation of an Atrial Flutter by Radiofrequency of the Cavotricuspid Isthmus.
NCT03919097 ·Status: COMPLETED
-
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
NCT06833138 ·Status: RECRUITING ·Phase: NA
-
Therapy of Atrial Flutter by Afib Ablation
NCT02051621 ·Status: UNKNOWN ·Phase: NA
-
ABLATOR Ablation Observational Registry
NCT02344173 ·Status: COMPLETED
-
Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study
NCT07129564 ·Status: RECRUITING
-
Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
NCT00352560 ·Status: COMPLETED ·Phase: PHASE3
-
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
NCT01803438 ·Status: COMPLETED ·Phase: PHASE4
-
FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
NCT03627806 ·Status: COMPLETED
-
An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting
NCT05471830 ·Status: COMPLETED
-
Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
NCT03508258 ·Status: WITHDRAWN
-
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NCT06207383 ·Status: RECRUITING ·Phase: NA